Our New Name: Carter Morse & Goodrich

carter morse and goodrich sign outside

September 9, 2018

We are delighted to announce that we are changing our name to Carter Morse & Goodrich.

Michael Carter, Founder and Managing Partner, commented "Our new name is in full recognition of the tremendous contribution that Ramsey Goodrich has made to our firm over the past 13 years. He is tireless not only in advising our clients but also building the firm and strengthening our reputation in the marketplace. He is an invaluable partner here at the firm and a dedicated leader in the M&A industry."

Frank Morse, Managing Director, added "While this change in name is exciting for us all, it does not change our continuing commitment to the success of our clients who are going through once-in-a lifetime transactions. We have all enjoyed working with Ramsey for years, and this recognition is well deserved."

We also recognize our continued association with Gary Mathias, who was a partner of the firm through 2015. Since 2016, Gary has served as CEO of Thetis Pharmaceuticals, a biopharmaceutical company co-founded by Gary, the partners of CMG and several ex-Pfizer R&D executives. Under Gary's leadership Thetis has raised $18 million of equity capital and grant funding, recruited a team of world class scientific and clinical advisors and advanced the development of potential first-in-class drug candidates for treatment of GI diseases. Gary has been and will continue to be a valued Senior Advisor to the CMG team.

The partners of Carter Morse & Goodrich look forward to the next 32 years of helping business owners plan, prepare, execute and ultimately close successful transactions.  Please contact us if CMG can help you or your clients.

About Carter Morse & Goodrich

Located in Southport, Connecticut, Carter Morse & Goodrich is a boutique M&A advisory firm that specializes in representing founder-led and family-held businesses valued between $25 million and $250 million. While CMG provides a full range of investment banking services, our primary focus is representing owners who are pursuing their once-in-a-lifetime M&A transactions. CMG specializes in advising leading companies in niche markets to plan, prepare, execute, and close successful transactions that maximize shareholder value. CMG fully understands and appreciates the unique dynamics of closely-held businesses and the importance of owner legacies. For 35 years, the combination of our hands-on approach, senior banker attention, strategic guidance, seamless transaction execution and extensive network of domestic and international resources has enabled us to become a trusted advisor to hundreds of business owners.

CMG's Broker/Dealer affiliate, Carter Capital Corporation, is a FINRA member firm registered with the SEC and SIPC.

More news >
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Join Our Mailing List

For more than three decades, Carter Morse & Goodrich has excelled at maximizing shareholder value for our clients and leading transactions through to successful completion.

Please enter your information below to receive email updates
from Carter Morse & Goodrich.